COR vs. JNJ
COR (Cencora Inc.) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — COR in Medical Distribution, JNJ in Drug Manufacturers - General. Over the past 10 years, COR returned 17.47%/yr vs 10.46%/yr for JNJ. At a 0.29 correlation, their price movements are largely independent.
Performance
COR vs. JNJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, COR achieves a -16.27% return, which is significantly lower than JNJ's 17.68% return. Over the past 10 years, COR has outperformed JNJ with an annualized return of 17.47%, while JNJ has yielded a comparatively lower 10.46% annualized return.
COR
- 1D
- 0.07%
- 1M
- 10.42%
- YTD
- -16.27%
- 6M
- -18.27%
- 1Y
- -3.81%
- 3Y*
- 17.14%
- 5Y*
- 20.65%
- 10Y*
- 17.47%
JNJ
- 1D
- 1.07%
- 1M
- 5.14%
- YTD
- 17.68%
- 6M
- 15.11%
- 1Y
- 57.60%
- 3Y*
- 17.82%
- 5Y*
- 10.94%
- 10Y*
- 10.46%
COR vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
COR Cencora Inc. | -16.27% | 51.48% | 10.37% | 25.33% | 26.26% | 44.09% | 23.37% | 23.51% | -17.57% | 19.51% |
JNJ Johnson & Johnson | 17.68% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
Correlation
The correlation between COR and JNJ is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Apr 4, 1995 | 0.29 |
Fundamentals
COR:
$55.03B
JNJ:
$588.98B
COR:
$13.07
JNJ:
$8.65
COR:
21.55
JNJ:
27.85
COR:
10.24
JNJ:
0.93
COR:
0.17
JNJ:
6.08
COR:
16.20
JNJ:
7.25
COR:
$328.68B
JNJ:
$96.36B
COR:
$11.66B
JNJ:
$66.60B
COR:
$3.64B
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
COR vs. JNJ — Risk / Return Rank
COR
JNJ
COR vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cencora Inc. (COR) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| COR | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.55 | ||
| Sortino ratioReturn per unit of downside risk | -4.91 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.61 | -0.60 |
| Calmar ratioReturn relative to maximum drawdown | -0.12 | 5.28 | -5.40 |
| Martin ratioReturn relative to average drawdown | -0.33 | 15.52 | -15.85 |
Loading charts...
Drawdowns
COR vs. JNJ - Drawdown Comparison
The maximum COR drawdown since its inception was -71.01%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for COR and JNJ.
Loading charts...
Drawdown Indicators
| COR | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.01% | -50.67% | -20.34% |
Max Drawdown (1Y)Largest decline over 1 year | -32.44% | -10.96% | -21.48% |
Max Drawdown (3Y)Largest decline over 3 years | -32.44% | -15.95% | -16.49% |
Max Drawdown (5Y)Largest decline over 5 years | -32.44% | -18.41% | -14.03% |
Max Drawdown (10Y)Largest decline over 10 years | -32.44% | -27.37% | -5.07% |
Current DrawdownCurrent decline from peak | -24.54% | -2.54% | -22.00% |
Average DrawdownAverage peak-to-trough decline | -13.62% | -11.90% | -1.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.68% | 3.72% | +7.96% |
Volatility
COR vs. JNJ - Volatility Comparison
Cencora Inc. (COR) has a higher volatility of 6.51% compared to Johnson & Johnson (JNJ) at 5.47%. This indicates that COR's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| COR | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.51% | 5.47% | +1.04% |
Volatility (6M)Calculated over the trailing 6-month period | 26.93% | 12.16% | +14.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.20% | 16.94% | +13.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.30% | 16.87% | +5.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.48% | 18.48% | +9.00% |
Dividends
COR vs. JNJ - Dividend Comparison
COR's dividend yield for the trailing twelve months is around 0.83%, less than JNJ's 2.18% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COR Cencora Inc. | 0.83% | 0.67% | 0.93% | 0.96% | 1.13% | 5.13% | 6.74% | 7.48% | 2.07% | 1.61% | 1.77% | 1.17% |
JNJ Johnson & Johnson | 2.18% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
Financials
COR vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Cencora Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
COR vs. JNJ - Profitability Comparison
COR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported a gross profit of 3.59B and revenue of 78.36B. Therefore, the gross margin over that period was 4.6%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
COR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported an operating income of 1.14B and revenue of 78.36B, resulting in an operating margin of 1.5%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
COR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported a net income of 1.64B and revenue of 78.36B, resulting in a net margin of 2.1%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
Frequently Asked Questions
COR and JNJ have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
COR has higher volatility (6.51%) compared to JNJ (5.47%). In terms of maximum drawdown, COR dropped -71.01% vs JNJ's -50.67%.
JNJ currently has the higher Sharpe Ratio (3.42 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for COR and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer